LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.

    Ellison, Corie A

    Regulatory toxicology and pharmacology : RTP

    2018  Volume 99, Page(s) 61–77

    Abstract: Physiologically based pharmacokinetic (PBPK) models enable simulations of absorption, distribution, metabolism, and elimination of chemicals from the body. Model evaluation is a key step in the PBPK model development processes whereby model predictions ... ...

    Abstract Physiologically based pharmacokinetic (PBPK) models enable simulations of absorption, distribution, metabolism, and elimination of chemicals from the body. Model evaluation is a key step in the PBPK model development processes whereby model predictions are compared to pharmacokinetic (PK) data. A prerequisite for PBPK model evaluation has always been the availability of PK data for the modeled compound, a requirement which has limited the use and acceptance of PBPK models since PK data is often limited or not available. The current work tests the hypothesis that an adequately developed PBPK model for a target chemical (chemical with no PK data) can be evaluated using PK data from a source chemical (chemical with existing PK data). Two different approaches for identifying the source chemical, a structural PK analog and functional PK analog technique, are used to evaluate a series of oral human PBPK models. Results show that both analog approaches can identify PK analogs which display similar PK as the target chemical and can be used as alternative ways for evaluating PBPK models. As animal free safety assessment strategies continue to develop, it's important to develop alternative approaches for PBPK model evaluation which does not rely on generating new PK data.
    MeSH term(s) Animals ; Humans ; Models, Biological ; Pharmaceutical Preparations/chemistry ; Pharmaceutical Preparations/metabolism ; Pharmacokinetics ; Risk Assessment ; Structure-Activity Relationship
    Chemical Substances Pharmaceutical Preparations
    Language English
    Publishing date 2018-09-08
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 604672-1
    ISSN 1096-0295 ; 0273-2300
    ISSN (online) 1096-0295
    ISSN 0273-2300
    DOI 10.1016/j.yrtph.2018.09.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Application of structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic model development and evaluation.

    Ellison, Corie A / Wu, Shengde

    Regulatory toxicology and pharmacology : RTP

    2020  Volume 114, Page(s) 104667

    Abstract: This work provides case studies for the pharmacokinetic (PK) analog approach, where a physiologically based pharmacokinetic (PBPK) model for a target chemical (has no PK data) is evaluated using PK data from a source chemical (has existing PK data). A ... ...

    Abstract This work provides case studies for the pharmacokinetic (PK) analog approach, where a physiologically based pharmacokinetic (PBPK) model for a target chemical (has no PK data) is evaluated using PK data from a source chemical (has existing PK data). A bottom up PBPK modeling approach (using in vitro and in silico inputs) is used to develop human oral PBPK models for caffeine and diphenhydramine. Models are evaluated using in vivo data from structural and functional PK analogs. At the end of the case studies, in vivo PK data for caffeine and diphenhydramine is introduced and both models were able to simulate plasma concentrations which agreed with the in vivo PK data. To further demonstrate that structural analogs can serve as PK analogs, in vitro metabolism and plasma protein binding was compared for a subset of structurally similar ToxCast chemicals and shown to be similar. Next steps for the PK analog approach should focus on evaluating this concept for a broader set of compounds. Using PK analogs for evaluating and establishing confidence in a PBPK model will ensure that PBPK modeling remains a viable option in animal alternative safety assessments.
    MeSH term(s) Animal Testing Alternatives ; Animals ; Caffeine/chemistry ; Caffeine/pharmacokinetics ; Diphenhydramine/chemistry ; Diphenhydramine/pharmacokinetics ; Humans ; Models, Biological ; Molecular Structure
    Chemical Substances Caffeine (3G6A5W338E) ; Diphenhydramine (8GTS82S83M)
    Language English
    Publishing date 2020-05-05
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 604672-1
    ISSN 1096-0295 ; 0273-2300
    ISSN (online) 1096-0295
    ISSN 0273-2300
    DOI 10.1016/j.yrtph.2020.104667
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data [Correction: Jan. 2023, 97(1), p. 311]

    Najjar, Abdulkarim / Ellison, Corie A. / Gregoire, Sebastien / Hewitt, Nicola J.

    Arch Toxicol 2023 Jan., v. 97, no. 1, p. 155-164

    2023  , Page(s) 155–164

    Abstract: We present a case study that provides a practical step-by-step example of how the internal Threshold of Toxicological Concern (iTTC) can be used as a tool to refine a TTC-based assessment for dermal exposures to consumer products. The case study uses a ... ...

    Abstract We present a case study that provides a practical step-by-step example of how the internal Threshold of Toxicological Concern (iTTC) can be used as a tool to refine a TTC-based assessment for dermal exposures to consumer products. The case study uses a theoretical scenario where there are no systemic toxicity data for the case study chemicals (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, octinoxate, and ecamsule). Human dermal pharmacokinetic data following single and repeat dermal exposure to products containing the case study chemicals were obtained from data published by the US FDA. The clinical studies utilized an application procedure that followed maximal use conditions (product applied as 2 mg/cm² to 75% of the body surface area, 4 times a day). The case study chemicals were first reviewed to determine if they were in the applicability domain of the iTTC, and then, the human plasma concentrations were compared to an iTTC limit of 1 µM. When assessed under maximum usage, the external exposure of all chemicals exceeded the external dose TTC limits. By contrast, the internal exposure to all chemicals, except oxybenzone, was an order of magnitude lower than the 1 µM interim iTTC threshold. This work highlights the importance of understanding internal exposure relative to external dose and how the iTTC can be a valuable tool for assessing low-level internal exposures; additionally, the work demonstrates how to use an iTTC, and highlights considerations and refinement opportunities for the approach.
    Keywords Food and Drug Administration ; case studies ; dermal exposure ; humans ; pharmacokinetics ; surface area ; toxicity ; toxicology
    Language English
    Dates of publication 2023-01
    Size p. 155-164
    Publishing place Springer Berlin Heidelberg
    Document type Article ; Online
    Note Use and reproduction
    ZDB-ID 124992-7
    ISSN 1432-0738 ; 0340-5761
    ISSN (online) 1432-0738
    ISSN 0340-5761
    DOI 10.1007/s00204-022-03371-6
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data.

    Najjar, Abdulkarim / Ellison, Corie A / Gregoire, Sebastien / Hewitt, Nicola J

    Archives of toxicology

    2022  

    Abstract: We present a case study that provides a practical step-by-step example of how the internal Threshold of Toxicological Concern (iTTC) can be used as a tool to refine a TTC-based assessment for dermal exposures to consumer products. The case study uses a ... ...

    Abstract We present a case study that provides a practical step-by-step example of how the internal Threshold of Toxicological Concern (iTTC) can be used as a tool to refine a TTC-based assessment for dermal exposures to consumer products. The case study uses a theoretical scenario where there are no systemic toxicity data for the case study chemicals (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, octinoxate, and ecamsule). Human dermal pharmacokinetic data following single and repeat dermal exposure to products containing the case study chemicals were obtained from data published by the US FDA. The clinical studies utilized an application procedure that followed maximal use conditions (product applied as 2 mg/cm
    Language English
    Publishing date 2022-09-23
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124992-7
    ISSN 1432-0738 ; 0340-5761
    ISSN (online) 1432-0738
    ISSN 0340-5761
    DOI 10.1007/s00204-022-03371-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Correction to: Practical application of the interim internal threshold of toxicological concern (iTTC): a case study based on clinical data.

    Najjar, Abdulkarim / Ellison, Corie A / Gregoire, Sebastien / Hewitt, Nicola J

    Archives of toxicology

    2022  

    Language English
    Publishing date 2022-11-27
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 124992-7
    ISSN 1432-0738 ; 0340-5761
    ISSN (online) 1432-0738
    ISSN 0340-5761
    DOI 10.1007/s00204-022-03398-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comparison between endocrine activity assessed using ToxCast/Tox21 database and human plasma concentration of sunscreen active ingredients/UV filters.

    Onyango, David O / Selman, Bastian G / Rose, Jane L / Ellison, Corie A / Nash, J F

    Toxicological sciences : an official journal of the Society of Toxicology

    2023  Volume 196, Issue 1, Page(s) 25–37

    Abstract: Sunscreen products are composed of ultraviolet (UV) filters and formulated to reduce exposure to sunlight thereby lessening skin damage. Concerns have been raised regarding the toxicity and potential endocrine disrupting (ED) effects of UV filters. The ... ...

    Abstract Sunscreen products are composed of ultraviolet (UV) filters and formulated to reduce exposure to sunlight thereby lessening skin damage. Concerns have been raised regarding the toxicity and potential endocrine disrupting (ED) effects of UV filters. The ToxCast/Tox21 program, that is, CompTox, is a high-throughput in vitro screening database of chemicals that identify adverse outcome pathways, key events, and ED potential of chemicals. Using the ToxCast/Tox21 database, octisalate, homosalate, octocrylene, oxybenzone, octinoxate, and avobenzone, 6 commonly used organic UV filters, were found to have been evaluated. These UV filters showed low potency in these bioassays with most activity detected above the range of the cytotoxic burst. The pathways that were most affected were the cell cycle and the nuclear receptor pathways. Most activity was observed in liver and kidney-based bioassays. These organic filters and their metabolites showed relatively weak ED activity when tested in bioassays measuring estrogen receptor (ER), androgen receptor (AR), thyroid receptor, and steroidogenesis activity. Except for oxybenzone, all activity in the endocrine assays occurred at concentrations greater than the cytotoxic burst. Moreover, except for oxybenzone, plasma concentrations (Cmax) measured in humans were at least 100× lower than bioactive (AC50/ACC) concentrations that produced a response in ToxCast/Tox21 assays. These data are consistent with in vivo animal/human studies showing weak or negligible endocrine activity. In sum, when considered as part of a weight-of-evidence assessment and compared with measured plasma concentrations, the results show these organic UV filters have low intrinsic biological activity and risk of toxicity including endocrine disruption in humans.
    MeSH term(s) Animals ; Humans ; Sunscreening Agents/toxicity ; Benzophenones/toxicity ; Receptors, Estrogen
    Chemical Substances Sunscreening Agents ; oxybenzone (95OOS7VE0Y) ; Benzophenones ; Receptors, Estrogen
    Language English
    Publishing date 2023-08-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1420885-4
    ISSN 1096-0929 ; 1096-6080
    ISSN (online) 1096-0929
    ISSN 1096-6080
    DOI 10.1093/toxsci/kfad082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Impact of chemical structure on the in vitro hydrolysis of fatty esters of 2-ethylhexanoic acid or 2-ethylhexanol and extrapolation to the in vivo situation.

    Obringer, Cindy / Lester, Cathy / Karb, Michael / Smith, Alex / Ellison, Corie A

    Regulatory toxicology and pharmacology : RTP

    2022  , Page(s) 105315

    Abstract: Fatty esters of 2-ethylhexanoic acid (EHA) and 2-ethylhexanol (EH) are commonly used in cosmetics. Human liver and skin S9 and human plasma were used to determine the in vitro rates of clearance ( ... ...

    Abstract Fatty esters of 2-ethylhexanoic acid (EHA) and 2-ethylhexanol (EH) are commonly used in cosmetics. Human liver and skin S9 and human plasma were used to determine the in vitro rates of clearance (CL
    Language English
    Publishing date 2022-12-06
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 604672-1
    ISSN 1096-0295 ; 0273-2300
    ISSN (online) 1096-0295
    ISSN 0273-2300
    DOI 10.1016/j.yrtph.2022.105315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Letter to the editor regarding recent publication titled "Developing an internal threshold of toxicological concern (iTTC)" by Arnot et al. (2022).

    Ellison, Corie A / Arnot, Jon A / Felter, Susan P / Daston, George P / Becker, Richard A / Toose, Liisa / Armitage, James M / Sangion, Alessandro / Looky, Alexandra / Brown, Trevor N / Li, Li

    Journal of exposure science & environmental epidemiology

    2023  Volume 33, Issue 5, Page(s) 840–841

    Language English
    Publishing date 2023-07-14
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2218551-3
    ISSN 1559-064X ; 1559-0631
    ISSN (online) 1559-064X
    ISSN 1559-0631
    DOI 10.1038/s41370-023-00571-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future.

    Ellison, Corie A / Api, Anne Marie / Becker, Richard A / Efremenko, Alina Y / Gadhia, Sanket / Hack, C Eric / Hewitt, Nicola J / Varcin, Mustafa / Schepky, Andreas

    Frontiers in toxicology

    2021  Volume 2, Page(s) 621541

    Abstract: The Threshold of Toxicological Concern (TTC) is a risk assessment tool for evaluating low-level exposure to chemicals with limited toxicological data. A next step in the ongoing development of TTC is to extend this concept further so that it can be ... ...

    Abstract The Threshold of Toxicological Concern (TTC) is a risk assessment tool for evaluating low-level exposure to chemicals with limited toxicological data. A next step in the ongoing development of TTC is to extend this concept further so that it can be applied to internal exposures. This refinement of TTC based on plasma concentrations, referred to as internal TTC (iTTC), attempts to convert the chemical-specific external NOAELs (in mg/kg/day) in the TTC database to an estimated internal exposure. A multi-stakeholder collaboration formed, with the aim of establishing an iTTC suitable for human safety risk assessment. Here, we discuss the advances and future directions for the iTTC project, including: (1) results from the systematic literature search for metabolism and pharmacokinetic data for the 1,251 chemicals in the iTTC database; (2) selection of ~350 chemicals that will be included in the final iTTC; (3) an overview of the
    Language English
    Publishing date 2021-01-15
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2673-3080
    ISSN (online) 2673-3080
    DOI 10.3389/ftox.2020.621541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Pharmacokinetics and pharmacodynamics of chlorpyrifos in adult male Long-Evans rats following repeated subcutaneous exposure to chlorpyrifos.

    Ellison, Corie A / Smith, Jordan Ned / Lein, Pamela J / Olson, James R

    Toxicology

    2011  Volume 287, Issue 1-3, Page(s) 137–144

    Abstract: Chlorpyrifos (CPF) is a commonly used organophosphorus pesticide. Several pharmacokinetic and pharmacodynamic studies have been conducted in rats in which CPF was administered as a single bolus dose. However, there is limited data regarding the ... ...

    Abstract Chlorpyrifos (CPF) is a commonly used organophosphorus pesticide. Several pharmacokinetic and pharmacodynamic studies have been conducted in rats in which CPF was administered as a single bolus dose. However, there is limited data regarding the pharmacokinetics and pharmacodynamics following daily exposure. Since occupational exposures often consist of repeated, daily exposures, there is a need to evaluate the pharmacokinetics and pharmacodynamics of CPF under exposure conditions which more accurately reflect real world human exposures. In this study, the pharmacokinetics and pharmacodynamics of CPF were assessed in male Long-Evans rats exposed daily to CPF (0, 3 or 10mg/kg/day, s.c. in peanut oil) over a 10 day study period. Throughout the study, multiple pharmacokinetic (urinary TCPy levels and tissue CPF and metabolite levels) and pharmacodynamic (blood and brain AChE activity) determinants were measured. Average blood AChE activity on day 10 was 54% and 33% of baseline among animals in the 3 and 10mg/kg/day CPF treatment groups, respectively, while average brain AChE activity was 67% and 28% of baseline. Comparable dose-response relationships between brain AChE inhibition and blood AChE inhibition, suggests that blood AChE activity is a valid biomarker of brain AChE activity. The pharmacokinetic and pharmacodynamic measures collected in this study were also used to optimize a rat physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model for multiple s.c. exposures to CPF based on a previously published rat PBPK/PD model for CPF following a single bolus injection. This optimized model will be useful for determining pharmacokinetic and pharmacodynamic responses over a wide range of doses and durations of exposure, which will improve extrapolation of results between rats and humans.
    MeSH term(s) Acetylcholinesterase/metabolism ; Animals ; Brain/enzymology ; Chlorpyrifos/administration & dosage ; Chlorpyrifos/pharmacokinetics ; Chlorpyrifos/pharmacology ; Injections, Subcutaneous ; Insecticides/pharmacokinetics ; Liver/metabolism ; Male ; Models, Biological ; Rats ; Rats, Long-Evans
    Chemical Substances Insecticides ; Acetylcholinesterase (EC 3.1.1.7) ; Chlorpyrifos (JCS58I644W)
    Language English
    Publishing date 2011-06-17
    Publishing country Ireland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 184557-3
    ISSN 1879-3185 ; 0300-483X
    ISSN (online) 1879-3185
    ISSN 0300-483X
    DOI 10.1016/j.tox.2011.06.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top